SCHEMBL8083835

SCHEMBL8083835

Cn1cc(NC(=O)Nc2ccc(-c3nc(N)cc(C4(S(C)(=O)=O)CCNCC4)n3)cc2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.39
GSK3B P49841 3/20 0.37
DYRK1A Q13627 3/20 0.37
PIK3CD O00329 2/20 0.35
KDR P35968 2/20 0.35
EGFR P00533 1/20 0.35
FGFR1 P11362 1/20 0.35
WNT1 P04628 1/20 0.35
PIK3CA P42336 3/20 0.35
ATR Q13535 2/20 0.35
MAOA P21397 1/20 0.35
MAPK1 P28482 1/20 0.35
AURKB Q96GD4 1/20 0.35
NTRK1 P04629 1/20 0.35
RET P07949 1/20 0.35
EPHB2 P29323 1/20 0.35
MAP4K1 Q92918 2/20 0.34
RPS6KA3 P51812 2/20 0.34
EPHX2 P34913 1/20 0.34
DHX9 Q08211 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091693 0.92 MTOR (0.40) MTORDYRK1APIK3CDKDREGFR
SCHEMBL8096057 0.90 MTOR (0.43) MTORPIK3CDPIK3CAATR
SCHEMBL8090739 0.86 PIK3CA (0.40) MTORPIK3CDPIK3CAATR
SCHEMBL8097088 0.83 TSHR (0.47) PIK3CDPIK3CAMAPK1AURKB
SCHEMBL8092066 0.82 PIK3CA (0.44) MTORPIK3CDPIK3CA
SCHEMBL4210741 0.82 MTOR (0.56) MTORPIK3CDPIK3CAATR
SCHEMBL8089909 0.81 MTOR (0.45) MTORGSK3BDYRK1APIK3CDWNT1
SCHEMBL8091635 0.80 ATR (0.47) MTORGSK3BDYRK1APIK3CDKDR
SCHEMBL8097448 0.79 PIK3CA (0.43) MTORPIK3CDPIK3CAATR
SCHEMBL8089194 0.79 MTOR (0.38) MTORDYRK1APIK3CDKDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed